Back to search

Switzerland· 36308052

Freka-Clyss, Klistier

A sodium phosphate product containing natrii dihydrogenophosphas anhydricus, dinatrii phosphas, registered in Switzerland by Fresenius Kabi (Schweiz) AG and dispensed under Swissmedic category D. The same ATC class is registered in 8 of our 19 countries.

Cat D (Swissmedic)ATC A06AG01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedFreka-Clyss, KlistierATCA06AG01REGISTER NO.36308052PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Sodium phosphate is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AG01 (sodium phosphate), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose

Sodium phosphate · ATC A06AG01

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
natrii dihydrogenophosphas anhydricus, dinatrii phosphas
Manufacturer
Fresenius Kabi (Schweiz) AG
Country
Switzerland (CH)
ATC code
A06AG01
ATC class
Sodium phosphate
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium phosphate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium phosphate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Italy · Phospho Lax, Sodio Fosfato Alfasigma
  • Netherlands · Colex Klysma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8cb2dce5-64fc-42b4-b71e-a2e4b13b5899
GET /v1/drugs/8cb2dce5-64fc-42b4-b71e-a2e4b13b5899?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about sodium phosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.